The European healthcare regulator has recommended the conditional approval of Gilead Sciences Inc's antiviral treatment remdesivir for use in Covid-19 patients, making it the first treatment to be on track to be green-lit in the continent.
from https://ift.tt/2YxoWVh
Sem comentários:
Enviar um comentário